Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct;112:49-57.
doi: 10.1016/j.phrs.2016.01.031. Epub 2016 Feb 2.

Recent Updates on GPCR Biased Agonism

Affiliations
Review

Recent Updates on GPCR Biased Agonism

André S Pupo et al. Pharmacol Res. .

Abstract

G protein-coupled receptors (GPCRs) are the most important targets for drug discovery and not surprisingly ∼40% of all drugs currently in the market act on these receptors. Currently, one of the most active areas in GPCRs signaling is biased agonism, a phenomenon that occurs when a given ligand is able to preferentially activate one (or some) of the possible signaling pathways. In this review, we highlight the most recent findings about biased agonism, including an extension of this concept to intracellular signaling, allosterism, strategies for assessment and interpretation, and perspectives of therapeutic applications for biased agonists.

Keywords: 7TMR; Functional selectivity; GPCR.

Similar articles

See all similar articles

Cited by 22 articles

See all "Cited by" articles

LinkOut - more resources

Feedback